Medical and Pharma Insider’s Post

MedNews: Holoclara closes $16 Million financing to advance worm-derived therapies for allergic and autoimmune disease Financing led by BOLD Capital Partners, alongside early investments from Horizons Ventures and participation from a syndicate of leading angel investors in the life sciences Capital to support clinical development of first-in-class, worm-derived medicines for allergies and autoimmune disorders and advancement of discovery engine https://wix.to/ojH89OB MedNews is a service of Medical and Pharma Insider, an FC Global Strategies Medical and Pharma Insider website: https://medicalandpharmainsidercom FC Global Strategies website: https://fcglobalstrategies;com #holoclara #therapeutics #mednews #medicalandpharmainsider

MedNews: Holoclara closes $16 Million financing to advance worm-derived therapies for allergic and autoimmune disease

MedNews: Holoclara closes $16 Million financing to advance worm-derived therapies for allergic and autoimmune disease

fcglobalstrategies.com

To view or add a comment, sign in

Explore topics